Risk reduction in HCM: when the gradient is gone, do we still need an ICD?

Back

ESC Premium Access

Risk reduction in HCM: when the gradient is gone, do we still need an ICD?

Session: Risk of sudden death in hypertrophic cardiomyopathy

Topic: Hypertrophic Cardiomyopathy

Speaker: Doctor A. Rigopoulos (Marousi, Athens, GR)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Angelos Rigopoulos

Mitera Hospital, Marousi, Athens (Greece)

7 presentations

2 followers

4 more presentations in this session

Prevention of sudden death in HCM - State of the art

Speaker: Professor P. Elliott (London, GB)

Access

Slides

Video

Prognostic role of late gadolinium enhancement in patients with low-intermediate 5 year HCM SCD risk score: a multicenter study.

Speaker: Doctor G. Todiere (Pisa, IT)

Implantable cardioverter defibrillator in patients with hypertrophic cardiomyopathy - A nationwide study

Speaker: Doctor A. Tsangaris (Minneapolis, US)

An international validation study of the 2014 european society of cardiology sudden cardiac death risk prediction model in childhood hypertrophic cardiomyopathy

Speaker: Professor P. Elliott (London, GB)

Access the full session

Risk of sudden death in hypertrophic cardiomyopathy

Speakers: Doctor A. Rigopoulos, Professor P. Elliott, Doctor G. Todiere, Doctor A. Tsangaris, Professor P. Elliott

Access

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources